Back to News
Market Impact: 0.1
REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Faruqi & Faruqi securities-litigation partner James Wilson is soliciting Regeneron investors who incurred losses to discuss potential legal options. The notice provides no details on alleged misconduct, damages, filing status, or financial impact on Regeneron.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
REGN-0.70
More News
- Regeneron extends Ebola treatment supply deal with US government
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- ‘Imposed significant financial harm’: 20 states join the FTC in suing Dollar General for ‘deceptive pricing practices’ despite ‘corporate knowledge’
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Anthropic’s dual-class share structure borrows ideas from Mark Zuckerberg, Elon Musk—and the New York Times
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock